The use of different dual X-ray absorptiometry brands in a multicenter clinical trial: consequences and limits.
Explore this paper's citation graph
Summary
The results of measurements of multibrand DXA apparatus in this multicenter study suggest several practical conclusions: (1) the CC should be performed by using a single phantom independent of the DXA brand tested; (2) duplicate measurements should been performed at the time of patient inclusion; and (3) the most efficient QC program should include CC, central reading of in vivo scans, and central review of daily QC.
- Type
- article
- Published
- 1999-03-01
- Cited by
- 30
- References
- 17
- OpenAlex
- https://openalex.org/W2012903403
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23361429
Keywords
Medicine, Bone mineral, Strontium ranelate, Coefficient of variation, Nuclear medicine
References
- Technical considerations of dual‐energy X‐ray absorptiometry‐based bone mineral measurements for pediatric studies
- Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
- Dual X‐ray absorptiometry quality control: Comparison of visual examination and process‐control charts
- Longitudinal precision of dual‐energy X‐ray absorptiometry in a multicenter study
- Dual X-ray absorptiometry--cross-calibration and normative reference ranges for the spine: results of a European Community Concerted Action.
- An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen‐deficient rats
- Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: A human cadaver study
- Bone mass measurement by DXA: Influence of analysis procedures and interunit variation
- Precision of dual‐energy x‐ray absorptiometry: Development of quality control rules and their application in longitudinal studies
- Calibration and standardization of bone mineral densitometers
- Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
- A multicenter comparison of dual‐energy X‐ray absorptiometers: In vivo and in vitro measurements of bone mineral content and density
- Comparison of four methods for cross‐calibrating dual‐energy x‐ray absorptiometers to eliminate systematic errors when upgrading equipment
- Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers
- Strontium ranelate as a treatment of vertebral osteoporosis
- Development of formulas for standardized DXA measurements
Cited by
- Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.
- Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
- Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies
- Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis
- Strontium ranelate for preventing and treating postmenopausal osteoporosis.
- Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
- Bone density monitoring with the total hip site: time for a re-evaluation?
- Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
- Factors Affecting Short‐Term Bone Density Precision Assessment and the Effect on Patient Monitoring
- Strontium ranelate and risk of vertebral fractures in frail osteoporotic women.
- Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis
- Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years
- Bone Mineral Density and Health Related Quality of Life: a 3-Year Follow-Up Study of Osteoporotic Postmenopausal Women
- CTXA Hip—An Extension of Classical DXA Measurements Using QCT
- Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
- CTXA Hip—An Extension of Classical DXA Measurements Using Quantitative CT
- Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older
- Vertebral Fracture Risk Reduction With Strontium Ranelate in Women With Postmenopausal Osteoporosis Is Independent of Baseline Risk Factors
- Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
- Strontium Ranelate Reduces the Risk of Vertebral Fractures in Patients With Osteopenia
Related papers
- Cost–effectiveness of strontium ranelate for the prevention and treatment of osteoporosis
- Strontium Ranelate: State of the Art
- Strontium ranelate--a promising therapeutic principle in osteoporosis.
- Социальное значение, экономическиеаспекты и новые возможности стронция ранелата в фармакотерапии постменопаузального остеопороза
- Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis.
- Dual-energy X-ray absorptiometry and bone density measurement
- Bone Mineral Density in the Lumbar Spine as Determined by Dual-Energy X-Ray Absorptiometry
- Challenges in clinical assessment of bone density and quality in children
- COMPARISON OF HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPTERIZED TOMOGRAPHY (HR-pQCT) WITH DUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) FOR MEASURING BONE MINERAL DENSITY (BMD)